menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Gland Pharma`s Generics Latanoprostene Receives Approval in US

    FDA

    Dr Reddy`s Generic Latanoprostene bunod Receives Tentative Approval in the U.S

    FDA

    FDA Confirms Paragraph IV Patent Litigation for Latanoprostene Bunod

    FDA

    Bausch Health Announces Vyzulta is Now Approved in South Korea

    EYEWIRE

    Bausch + Lomb Announces Additional Expanded Public Coverage for (Pr)VYZULTA®

    NEWSWIRE

    Bausch Announces VYZULTA®, 0.024%, is Now Approved In Seven Countries

    PRNEWSWIRE

    Nicox’s Partner Secures Additional Approvals of VYZULTA

    GLOBE NEWSWIRE

    Nicox and Fera Pharmaceuticals Focus on Rare Disease Indication for Naproxcinod

    GLOBENEWSWIRE

    FDA rejects Duobrii, a Valeant `Significant Seven` drug

    FIERCE PHARMA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.